Introduction
Anchorage-independent growth is a hallmark of malignant tumor cells (Freedman and Shin, 1974) . In contrast to nonmalignant cells, cancer cells can thus grow and survive without attaching themselves to the substratum. Moreover, cellular tumorigenicity in nude mice is correlated with anchorage-independent growth in vitro. This characteristic has been known for decades, and it has been suggested that alterations in cell-cell adhesion molecules, integrins or integrin-associated signaling molecules in cancer cells may be involved in anchorage-independent growth (Frisch and Ruoslahti, 1997) . However, the details of the underlying molecular mechanisms are still not fully understood.
The c-jun immediate-early gene is the cellular homolog of the oncogene v-jun, which was originally identified as the transforming principle of avian sarcoma virus 17. c-jun is transcribed rapidly and at high levels with a variety of stimuli, including serum growth factors and mitogens, forms dimeric complexes with members of the fos, ATF or MAF families, and binds to 12-Otetradecanoylphorbol-13-acetate-responsive or cAMPresponsive elements in promoter region of genes implicated in the regulation of cell proliferation, differentiation and apoptosis (Vogt, 2001; Shaulian and Karin, 2002) . Substantial evidence supports the notion that c-jun plays a role in cellular transformation (Young et al., 1999; Eferl et al., 2003) . It has been established that this oncogenic activity is exerted as a single gene in an immortalized rat fibroblast cell line, Rat1a, and also in cooperation with other oncoproteins, such as activated ras, in nonmalignant rodent cells (Schutte et al., 1989) .
Lung cancer is the leading cause of cancer death in many industrialized countries and its cure rate remains dismally low, despite continuing efforts of clinicians. However, molecular biological studies have already shed a great deal of light on the molecular pathogenesis of lung cancers, demonstrating the existence of multiple genetic alterations such as activation of oncogenes and inactivation of tumor-suppressor genes during the processes of carcinogenesis (Osada and Takahashi, 2002) . Previous immunohistochemical studies revealed that the c-jun oncoprotein is highly expressed in 31-50% of NSCLC patients (Wodrich and Volm, 1993; Szabo et al., 1996) , and may even be upregulated in atypical bronchial epithelium (Szabo et al., 1996) , suggesting a role in early events in the pathogenesis of lung cancers although exact functional consequences remain rather elusive.
In the present study, we focused on acquisition of anchorage independence in the process of lung cancer development. We show here that in contrast to other immediate-early genes such as c-fos and c-myc, serumstimulated induction of c-jun is anchorage dependent in an immortalized human bronchial epithelial cell line, but that lung cancer cell lines frequently exhibit loss of such anchorage dependence. Furthermore, constitutive expression of a dominant-negative mutant of c-jun inhibited anchorage independent but not anchoragedependent growth of a lung cancer cell line with dysregulated c-jun expression.
Results
Anchorage-dependent induction of c-jun by serum stimulation in BEAS-2B Induction of c-jun in response to serum stimulation in BEAS-2B cells was examined in the presence or absence of anchorage, together with expression of two other immediate-early genes, c-fos and c-myc, by Western blot analysis. Cells were serum-starved for 24 h and refed with fresh medium containing 1% FCS. As shown in Figure 1 , the c-fos and c-myc proteins were rapidly and markedly induced by serum stimulation under both anchorage-dependent and -independent conditions. In contrast, c-jun protein was rapidly and markedly induced by serum stimulation only in the presence of anchorage. Lack of serum-induced increase in c-jun expression appeared to be transcriptional, since 30 min after serum stimulation in the absence of anchorage Northern blot analysis showed no induction of c-jun transcripts, in marked contrast to upregulation of c-fos (data not shown). The observed delays in the induction of proteins are consistent with previous reports, and are presumably due to the time lag in translation into protein (Muller et al., 1984) .
Anchorage-independent growth of BEAS-2B cells with constitutive expression of c-jun The finding that, only in the absence of anchorage c-jun was not induced by serum stimulation, prompted us to examine what the biological outcome would be if there was constitutive elevated expression of c-jun in BEAS-2B cells, especially under anchorage-independent conditions. A tetracycline-off gene expression system, in which addition of tetracycline to the culture media shuts off the gene transcription, was employed to regulate expression of c-jun. A representative stable transfectant clone, c-jun-7 (BEAS-2B-tet-c-jun), was used for further experiments, in which c-jun was clearly induced by the removal of tetracycline from the culture medium (Figure 2a) . Induction of c-jun expression did not cause noticeable changes in cell morphology, at least within the first few weeks (Figure 2b) , and there were no apparent changes in proliferation in either Cont-4 (BEAS-2B-tet) or c-jun-7 cells, regardless of the presence or absence of tetracycline, under adherent growth conditions (Figure 2c ).
To investigate the effects of c-jun expression on the anchorage-independent growth, BEAS-2B cells were grown in soft agar for 14 days in the presence or absence of tetracycline. In the c-jun-induced state, numerous colonies were formed in soft agar, although they were small in size (Figure 2d) . Effects of the forced c-jun expression on cell viability in soft agar were also analysed by examining the proportion of cells stained with MTT at different time points with and without the addition of tetracycline. Compared with c-jun-induced cells, reduced viability of the cells in the non-c-juninduced state was observed in both Cont-4 and c-jun-7 cells (Figure 2e ). These results suggested that constitutive elevated expression of c-jun conferred on immortalized human bronchial epithelial cells the ability to survive in the absence of anchorage, thus allowing c-junexpressing BEAS-2B cells to form colonies in soft agar.
Mutational activation of the K-ras oncogene, which is thought to play an important role in the pathogenesis of lung cancers (Rodenhuis et al., 1987) , has been shown to cooperate with c-jun in some systems (Schutte et al., 1989) . We therefore investigated whether coexpression of c-jun and K-ras in BEAS-2B cells might have differential effects depending on the presence or absence of anchorage. To this end, a CMV promoter-driven constitutive expression vector harboring a missense mutation at codon 12 (Gly to Val) of K-ras or a control vector was introduced into the c-jun-7 and Cont-4 cells to generate the respective stable transfectants. Clones were isolated from individual blasticidin-resistant colonies and examined for expression of mutant K-ras at comparable levels to the endogenous wild-type K-ras by RT-PCR-SSCP analysis, which can distinguish expression of wild-type and mutant K-ras alleles (data not shown). It was found that constitutive expression of mutant K-ras resulted in modest morphological changes, the cells being generally spindle shaped (CK3 and JK1 shown in Figure 3a ), but significant differences in the rate of cell growth under adherent conditions were not observed among the transfectants, regardless of the Figure 1 Anchorage-dependent induction of c-jun by serum stimulation in BEAS-2B. Western blot analysis of the kinetics of induction of immediate early genes after serum stimulation under both anchorage-dependent (monolayer) and -independent (suspension) conditions. Note the lack of serum-induced increase in c-jun expression under anchorage-independent conditions. a-tubulin served as loading control.
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K Maeno et al presence or absence of K-ras and/or c-jun expression ( Figure 3b ). Interestingly, whereas numbers of small colonies formed in soft agar were similar between transfectants expressing c-jun alone and those expressing both c-jun and K-ras (data not shown), the ability to form large colonies, a characteristic feature of malignant cells (Freedman and Shin, 1974) , was significantly increased on coexpression of c-jun and K-ras (Figures 3c and d ). Taken together, these findings clearly showed that c-jun confers on human bronchial epithelial cells the ability to survive in the absence of anchorage, and cooperates with the activated K-ras gene for full transformation, although it may not significantly alter cell morphology or stimulate cell growth in the presence of anchorage.
Altered regulation of c-jun expression in human lung cancer cell lines under anchorage-independent conditions
We next asked whether lung cancer cell lines exhibit altered regulation of c-jun under anchorage-independent conditions. When cells were stimulated by serum in the absence of anchorage, regulation of c-jun expression was markedly different between the BEAS-2B, bronchial epithelial cell line, and seven (41%) of the 17 human lung cancer cell lines examined in this study ( Figure 4 ). Among the seven lung cancer cell lines in which altered regulation of c-jun expression were observed, five cell lines exhibited complete lack of downregulation of c-jun expression after 24 h-incubation in the absence of anchorage (data shown for RERF-LC-AI and VMRC-LCD), while two lines even featured marked induction of c-jun expression (data shown for ACC-LC-176).
Expression of c-jun in the remaining 10 cell lines was found to be regulated as BEAS-2B (data shown for RERF-LC-OK).
Inhibition of anchorage-independent growth by the introduction of a dominant-negative form of c-jun into the RERF-LC-AI human lung cancer cell line We observed that forced expression of c-jun considerably stimulated anchorage-independent growth of BEAS-2B cells, and that a large fraction of lung cancer cell lines showed loss of anchorage dependence in the regulation of c-jun expression. These findings prompted us to investigate whether functional inhibition of c-jun could suppress anchorage-independent growth of lung cancer cell lines with altered c-jun regulation. A dominant-negative mutant of c-jun lacking the transactivation domain was employed to further examine this phenomenon and introduced into the RERF-LC-AI human lung cancer cell line, which exhibited sustained c-jun expression in the absence of anchorage. Expression of the dominant-negative mutant form of c-jun in bulk culture of stable transfectants was confirmed by Western blot analysis (Figure 5a ). Such bulk cultures were employed for cell growth analyses under anchoragedependent and -independent conditions to avoid effects of clonal differences. No apparent difference in cell growth was observed in the presence of anchorage between the dominant-negative-c-jun-and empty-vector-transfected cells (Figure 5b ). In contrast, we observed a marked reduction in the number of large colonies formed in the absence of anchorage in the dominant-negative-c-jun-transfected cells when compared with transfectants receiving an empty vector, suggesting that dysregulated constitutive c-jun expression 
Discussion
It is well known that oncogenes such as K-ras, c-myc and c-jun are often activated or overexpressed in human lung cancers (Wodrich and Volm, 1993; Szabo et al., 1996; Osada and Takahashi, 2002) . However, the functional consequences of such oncogene activation in the development and progression of human lung cancers are not yet fully understood. The present study, initiated to elucidate the underlying mechanisms as for how lung epithelial cells acquire anchorage independence, led us to identify dysregulation of c-jun as a potential factor in a large fraction of human lung cancer cell lines. The immortalized human bronchial epithelial Figure 4 Altered regulation of c-jun expression in human lung cancer cell lines under anchorage-independent conditions. The upper panels show results from an immortalized bronchial epithelial cell line, BEAS-2B, and a representative lung cancer cell line, in which expression of c-jun was found to be regulated as BEAS-2B. The lower panels show representative results from lung cancer cell lines that display altered regulation of c-jun under anchorage-independent conditions. Total cell lysates were isolated at the indicated time points after serum stimulation under anchorage-dependent ( þ ) or -independent (À) conditions. a-tubulin served as loading control. Altered c-jun expression in lung cancers K Maeno et al cell line, BEAS-2B, was found to lack serum-stimulated induction of c-jun in the absence of anchorage. Under the same conditions, we observed robust induction of c-fos and c-myc, other early immediate genes. Constitutive expression of exogenously introduced c-jun furthermore stimulated survival in the absence of anchorage, with coexpression of mutant K-ras leading to full transformation. It is of note that such anchorage-dependent regulation of c-jun was found for the first time to be lost in a significant proportion of human lung cancer cell lines. Furthermore, dominant-negative c-jun significantly reduced the anchorage-independent growth in a lung cancer cell line. These findings support the notion that alterations in the anchorage-dependent regulation of c-jun expression may play a role in the acquisition of anchorage independence, a prominent feature of malignant cells. In this connection, Szabo et al. (1996) previously reported the presence of frequent overexpression of c-jun even in histologically atypical lung epithelial cells in marked contrast to undetectable c-jun expression in normal lung epithelium, and suggested that alteration in c-jun expression may be an early event in the process of human lung carcinogenesis.
Apoptosis following loss of cell anchorage, cellextracellular matrix anchorage as well as cell-cell anchorage, is relevant for development, tissue homeostasis and disease and is termed 'anoikis'. Disruption of cell-matrix adhesion in a suspension culture induces anoikis in normal epithelial cells and cell-cell adhesion/ aggregation has been shown to prevent such an event (Frisch and Ruoslahti, 1997; Frisch and Screaton, 2001 ). Expression of the antiapoptotic bcl-2 gene may be preserved in aggregated bronchial epithelial cells in suspension culture and is believed to play a role in inhibition of anoikis (Aoshiba et al., 1997) . In this connection, it is of note that upregulation of bcl-2 frequently occurs in lung cancers (Ben-Ezra et al., 1994; Ikegaki et al., 1994) and that human bcl-2 positively regulates expression of c-jun (Feng et al., 2004) . While overexpression of programmed cell death gene 4 (pdcd4), which is a candidate transformation-suppressor gene induced during apoptotic processes (Cmarik et al., 1999) , has been shown to inhibit anchorage-independent growth by inhibiting transactivation of c-jun (Yang et al., 2003) . Interestingly, pdcd4 protein expression was previously shown to be lost in 83% of primary lung cancer cases and linked with a poor prognosis (Chen et al., 2003) . These findings may account for part of the underlying molecular mechanisms of dysregulation of c-jun expression in human lung cancer that we have demonstrated in our study. Further studies are thus warranted to determine how human lung cancer acquires altered regulation of c-jun expression.
While c-jun is known to regulate a wide range of cellular processes including proliferation, death, survival and differentiation (Vogt, 2001; Shaulian and Karin, 2002) , in many cases the downstream target genes mediating each of these functions have not yet been identified in detail. Several potential downstream targets for c-jun have been detected in relation to anchorageindependent growth, by using different cells or systems (Lu et al., 2002; Kinoshita et al., 2003; Hommura et al., 2004; Katabami et al., 2005) . Stathmin, HMG-I/Y or cyclin A has been reported as a candidate downstream target of c-jun in connection with the acquisition of the ability of anchorage-independent growth (Kinoshita et al., 2003; Hommura et al., 2004; Katabami et al., 2005) . Furthermore, Lu et al. (2002) recently demonstrated that g-synuclein, which is highly upregulated in a large fraction of invasive and metastatic breast cancers, is a downstream target of c-jun in soft agar growth of T47D breast cancer cells. We therefore examined whether the introduction of dominant-negative c-jun affected the expression of these proteins, which could be involved in the anchorage-independent growth of lung cancer cells. Whereas constitutive expression of dominant-negative c-jun significantly inhibited the anchorage-independent growth of RERF-LC-AI, we did not observe appreciable downregulation in stathmin, HMG-I/Y or cyclin A proteins under anchorage-independent conditions (data not shown). Moreover, the g-synuclein protein was not expressed in RERF-LC-AI cells Altered c-jun expression in lung cancers K Maeno et al regardless of the presence or absence of the dominantnegative c-jun (data not shown). Although these genes appear to be candidates for downstream targets of c-junmediated anchorage-independent growth in lung cancer cells, our findings indicate that the encoded molecules are not primarily responsible for c-jun-mediated-anchorage-independent growth, at least in the lung cancer cell line analysed in this study. It would be of major interest to explore novel downstream targets of c-jun-mediated transactivation that are responsible for the acquisition of this biological property in human lung epithelial cells. For this reason, further analyses are needed, such as comprehensive expression profiling of genes and proteins with microarrays, two-dimensional gel electrophoresis coupled with mass spectrometry and multidimensional HPLC combined with tandem mass spectrometry.
In the study reported here, we did not observe that induction of c-jun expression in BEAS-2B caused noticeable changes in cell morphology. Similar results have been obtained in a study utilizing chicken embryo fibroblasts, showing that c-jun overexpressing cells were morphologically normal (Castellazzi et al., 1990) . On the other hand, other published studies have shown that induction of c-jun resulted in altered cell morphology (Schutte et al., 1989; Suzuki et al., 1991; Kinoshita et al., 2003) . This discrepancy could be due to differences in the type of cells used or in experimental conditions.
We also showed that exogenous expression of activated K-ras in BEAS-2B resulted in modest morphological changes, but that it did not affect the ability to form large colonies in soft agar culture. In contrast, a few previous studies have shown that activated ras can alter the transplantability of BEAS-2B (Amstad et al., 1988; Reddel et al., 1988b Reddel et al., , 1995 . These findings suggest that in these previous experiments c-jun expression may have been constitutively sustained during the selection of the activated K-ras-transfected stable clones.
In conclusion, the results of the present study suggest that dysregulated c-jun expression may play a role in the pathogenesis of human lung cancers by contributing to the acquisition of anchorage independence. Further investigations are warranted to comprehensively elucidate the molecular mechanisms by which constitutive expression of c-jun allows lung cancer cells to escape from cell death under anchorage-independent conditions. It also clarifies the background to dysregulated c-jun expression in lung cancer cells. Further delineation of the involved pathways should help us to understand the molecular pathogenesis of lung cancers and may ultimately lead to the identification of novel molecular targets for the prevention and treatment of this fatal disease.
Materials and methods

Cell lines and culture
An immortalized human bronchial epithelial cell line, BEAS-2B (Reddel et al., 1988a) was cultured in Ham's F-12 medium supplemented with 1% fetal calf serum (FCS), 5 mg/ml of bovine insulin, 5 mg/ml of human transferrin, 10 À7 M hydrocortisone, 2 Â 10 À10 M triiode thyronine, 100 U/ml of penicillin and 100 mg/ml of streptomycin at 371C in the presence of 5% CO 2 . A series of human NSCLC cell lines were maintained in RPMI 1640 medium supplemented with 5% FCS, 100 U/ml of penicillin and 100 mg/ml of streptomycin at 371C in the presence of 5% CO 2 . For serum starvation/induction studies, logarithmically growing cells were serum-starved for 24 h and refed with fresh medium containing FCS, then harvested at appropriate time points.
Western blot analysis
Equal amounts of total cell lysates solubilized in Laemmli's sample buffer were electrophoresed on 10 or 15% SDSpolyacrylamide gels and transferred to Immobilon-P filters (Millipore, Bedford, MA, USA). The filters were first incubated with primary antibodies overnight at 41C (g-synuclein and HMG-I/Y) or for 1 h at room temperature (c-fos, c-myc, c-jun, stathmin, cyclin A and a-tubulin) and then with horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology, Beverly, MA, USA). The primary antibodies against c-fos, c-myc, g-synuclein, HMG-I/Y and cyclin A were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), c-jun and stathmin from Calbiochem (La Jolla, CA, USA), and a-tubulin from Sigma (St Louis, MO, USA). For visualization, an enhanced chemiluminescence system (Amersham, Buckinghamshire, UK) was applied.
Northern blot analysis
Extraction of RNA from cell lines as well as Northern blot analysis using 5 mg each of the extracted total RNAs was conducted according to standard procedures using a 0.5-kb HincII fragment of a c-jun cDNA clone (pVcos-7neo-c-jun) (Schutte et al., 1989 ) and a 2.1-kb EcoRI fragment of a c-fos cDNA clone (pLfosSN) covering the entire coding region (Fujita and Shiku, 1995) .
Plasmids and transfection
A tetracycline-off gene expression system in BEAS-2B cells was employed essentially as described previously (Yanagisawa et al., 1998) . pT2GN-c-jun was constructed by subcloning the entire coding region of c-jun cDNA from the pVcos-7neo-c-jun (Schutte et al., 1989) into pT2GN (Ookawa et al., 1997) . To establish inducible c-jun clones (BEAS-2B-tet-c-jun), pTAhyg-transfected BEAS-2B cells, which had been selected with 100 mg/ml hygromycin B (Sigma), were transfected with 2 mg of pT2GN-c-jun using a cationic lipid reagent, DMRIE-C (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions and selected with 200 mg/ml G418 (Invitrogen). For generating transfectants doubly transfected with inducible c-jun and K-ras, BEAS-2B-tet-c-jun cells and BEAS-2B-tet cells were secondarily transfected with pcDNA3-KrasV12 carrying an activating mutation at codon 12 of K-ras and an empty pcDNA3, respectively, together with pMAM2-BSD (Funakoshi, Tokyo, Japan), at a molar ratio of 9:1 using DMRIE-C. The transfected cells were then selected using 8 mg/ ml blasticidin (Funakoshi) and propagated into stable clones.
A dominant-negative mutant of c-jun, identical to that termed TAM67 (Brown et al., 1993) , was prepared by polymerase chain reaction (PCR) using the sense primer 5 0 -GATGATATCATGACTAGCCAGAACACGCTGCCCA G-3 0 and the anti-sense primer 5 0 -GATGCTAGCAAATG TTTGCAACTGCTGCG-3 0 . The resulting PCR product was digested with NheI and EcoRV, subcloned into pIRESpuro2 (Clontech Laboratories, Inc., Palo Alto, CA), and sequenced thoroughly to ensure its integrity. The expression vector (or an empty vector) was transfected into the RERF-LC-AI lung cancer cell line using DMRIE-C and transfected cells were selected using 2 mg/ml puromycin and propagated as stable clones.
Anchorage-independent culture Colony formation in soft agar was assayed essentially as described previously (Masuda et al., 1997) . In brief, aliquots of 2.5 Â 10 4 cells were suspended in 1.5 ml of standard medium containing 0.33% Noble agar (DIFCO, Detroit, MI, USA) at 431C, and layered on 1 ml of solidified 0.5% Noble agar in the culture medium in 35-mm culture dishes. In some experiments, 1 mg/ml of tetracycline was supplied to both layers to repress expression of exogenous c-jun. Dishes were incubated at 371C in 5% CO 2 for 2 weeks. Cells were fed with the culture medium once a week and viable colonies were stained with p-iodonitrotetrazolium violet (Sigma), and classified as large (more than 30 cells) and small (10-30 cells). At least two independent experiments were performed in triplicate.
In order to evaluate the effect of loss of anchorage, viability was measured by staining cells with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), essentially as detailed previously (Hida et al., 1989) . Cells were seeded in soft agar as described above and incubated for the indicated time period before addition of 0.5 ml of 0.5% MTT solution dissolved in PBS. After an additional 3-h-incubation, numbers of stained and unstained cells were counted under a light microscope. Cell viability was calculated as the percentage of the stained cells in the total counted. For biochemical analyses of cells in suspension culture, cells were inoculated in dialyzed 0.65% methylcellulose (Katayama Chemical, Osaka, Japan) dissolved in the culture medium, and incubated at 371C for given periods of time.
Analysis of anchorage-dependent cell growth Cells were dissociated with 0.1% trypsin and 0.05% EDTA in PBS for 5 min at 371C, plated into 35-mm dishes (2.5 or 5 Â 10 4 cells/dish) and cultured in standard medium in the presence or absence of 1 mg/ml of tetracycline. Medium was changed every other day. Cells of triplicate samples were dissociated by trypsinization and counted with a Coulter counter (Coulter Electronics, Luton, UK) on days 1, 3, 5 and 7. At least two independent experiments were performed in triplicate.
